Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMQH2SF)

Drug Name

IPH4102 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
T-cell lymphoma	2A90	Phase 2	[1]

Cross-matching ID

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
MHC class I NK cell receptor 3DL2 (CD158k)	TTQH3N0	KI3L2_HUMAN	Antagonist	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03902184) IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma (TELLOMAK). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)